Retatrutide in Australia: A Promising Solution for Weight Loss ?
Australia is currently observing the arrival of retatrutide, a novel dual GIP and GLP-1 receptor agonist , representing a exciting advance in obesity treatment . Early research findings have demonstrated impressive results, showing greater effectiveness than existing treatments like semaglutide.